Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease

Respirology

Volumn 19, Issue 8, 2014, Pages 1215-1221

  Holland, Anne E ^a,b,c   Fiore, Julio F ^a,b,c   Bell, Emily C ^b   Goh, Nicole ^a,c,d   Westall, Glen ^a   Symons, Karen ^a   Dowman, Leona ^b,c,d   Glaspole, Ian ^a  

^a ALFRED HEALTH   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c INSTITUTE FOR BREATHING AND SLEEP   (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

Anxiety; Comorbidity; Depression; Dyspnoea; Interstitial lung disease

Indexed keywords

PREDNISOLONE;

ADULT; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPERTENSION; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; ISCHEMIC HEART DISEASE; LYMPHANGIOLEIOMYOMATOSIS; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; OSTEOARTHRITIS; OSTEOPOROSIS; PREVALENCE; RESPIRATORY FUNCTION; SARCOIDOSIS; SLEEP DISORDERED BREATHING; SMOKING; WALKING; AGED; AUSTRALIA; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR;

AGED; ANXIETY; AUSTRALIA; COMORBIDITY; DEPRESSION; DYSPNEA; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; WALKING;

EID: 84908024322     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12360     Document Type: Article

References (26)

1. Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR. Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest 2011; 139: 609-16.
2. De Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur. Respir. J. 2001; 17: 954-61.
3. Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology 2012; 17: 525-32.
4. Sanchez O, Caumont-Prim A, Gillet-Juvin K, Callens E, Graba S, Essalhi M, Chevalier-Bidaud B, Israel-Biet D, Mahut B, Delclaux C. Activity-related dyspnea is not modified by psychological status in people with COPD, interstitial lung disease or obesity. Respir. Physiol. Neurobiol. 2012; 182: 18-25.
5. Tzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur. J. Intern. Med. 2005; 16: 105-12.
6. Coelho AC, Knorst MM, Gazzana MB, Barreto SS. Predictors of physical and mental health-related quality of life in patients with interstitial lung disease: a multifactorial analysis. J. Bras. Pneumol. 2010; 36: 562-70.
7. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63(Suppl. 5): v1-58.
8. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA et al. An official ATS/ERS/JRS/ALAT Statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788-824.
9. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111-17.
10. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur. Respir. J. 2010; 36: 1067-72.
11. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63: 549-54.
12. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983; 67: 361-70.
13. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J. Psychosom. Res. 2002; 52: 69-77.
14. Lindell KO, Olshansky E, Song MK, Zullo TG, Gibson KF, Kaminski N, Hoffman LA. Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart Lung 2010; 39: 304-13.
15. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE Jr, Collard HR. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2011; 184: 1390-4.
16. Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir. Med. 2010; 104: 1035-41.
17. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE, Ryu J, Collard HR. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013; 144: 234-40.
18. Collard HR, Ward AJ, Lanes S, Cortney Hayflinger D, Rosenberg DM, Hunsche E. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ. 2012; 15: 829-35.
19. Hinz A, Brahler E, Mode R, Wirtz H, Bosse-Henck A. Anxiety and depression in sarcoidosis: the influence of age, gender, affected organs, concomitant diseases and dyspnea. Sarcoidosis Vasc. Diffuse Lung Dis. 2012; 29: 139-46.
20. Wolfe F, Michaud K. Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis Rheum. 2009; 61: 667-73.
21. Ferreira A, Garvey C, Connors GL, Hilling L, Rigler J, Farrell S, Cayou C, Shariat C, Collard HR. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135: 442-7.
22. Swigris JJ, Fairclough DL, Morrison M, Make B, Kozora E, Brown KK, Wamboldt FS. Beneficial effects of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir. Care 2011; 56: 783-9.
23. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J. Psychosom. Res. 2007; 63: 551-65.
24. Holland A, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst. Rev. 2008; CD006322.
25. Yorke J, Swigris J, Russell AM, Moosavi SH, Ng Man Kwong G, Longshaw M, Jones PW. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 2011; 139: 159-64.
26. Bratas O, Gronning K, Forbord T. Psychometric properties of The Hospital Anxiety and Depression Scale and The General Health Questionnaire-20 in COPD inpatients. Scand. J. Caring Sci. 2013; 28: 413-20.